REFERENCES
- Zivadinov R, Bakshi R, eds. Brain and Spinal Cord Atrophy in Multiple Sclerosis, Hauppauge, NY: Nova Science, 2004
- Hardmeier M, Wagenpfeil S, Freitag P, et al. Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis. Arch Neurol 2003; 60: 1736–1739
- Rudick RA, Fisher E, Lee JC, et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999; 53: 1698–1704
- Zivadinov R, Grop A, Sharma J, et al. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis. J Neuroimaging 2005; 15: 27–36
- Garrison K, Henry RG, Pelletier D. The measurement of brain atrophy in multiple sclerosis: Technical aspects. In: Zivadinov R, Bakshi R, eds. Brain and Spinal Cord Atrophy in Multiple Sclerosis, Hauppauge, NY: Nova Science, 2004: pp. 39–62
- Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001; 5: 143–156
- Jenkinson M, Bannister P, Brady M, et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825–841
- Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452
- Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907–911
- Bermel RA, Sharma J, Tjoa CW, et al. A semiautomated measure of whole-brain atrophy in multiple sclerosis. J Neurol Sci 2003; 208: 57–65
- Zivadinov R, Bagnato F, Nasuel I i D, et al. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis. J Neurol Sci 2004; 223: 185–193
- Horsfield MA, Rovaris M, Rocca MA, et al. Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. J Neurol Sci 2003; 216: 169–177
- Smith SM, De Stefano N, Jenkinson M, et al. Normalized accurate measurement of longitudinal brain change. I Comput Assist Tomogr 2001; 25: 466–475
- Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479–489